Key Metrics
CiteScore 

6.5
Eigenfactor 

0.001 - 0.005
H-Index 

40
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

1.27
Recommended pre-submission checks
Powered by 

Topics Covered on Current Hematologic Malignancy Reports
Current Hematologic Malignancy Reports Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | CURRENT MEDICINE GROUP |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Hematologic Malignancy Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Hematologic Malignancy Reports
Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era.
- 7 Aug 2026
- Current hematologic malignancy reports
Antigen Pressure, Clonal Evolution, and Lineage Plasticity in B-Cell Acute Lymphoblastic Leukemia: Resistance Biology in the Immunotherapy Era.
- 7 Aug 2026
- Current hematologic malignancy reports
Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia.
- 13 Jul 2026
- Current hematologic malignancy reports
Correction: Clonal Signatures of Telomere Biology Disorders.
- 10 Jul 2026
- Current hematologic malignancy reports
BRAF Alterations in Chronic Lymphocytic Leukemia: Genomic Landscape, Co-Mutation Patterns, and Clinical Relevance.
- 1 May 2026
- Current hematologic malignancy reports
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
- 25 Apr 2026
- Current hematologic malignancy reports
Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era.
- 7 Aug 2026
- Current hematologic malignancy reports
Antigen Pressure, Clonal Evolution, and Lineage Plasticity in B-Cell Acute Lymphoblastic Leukemia: Resistance Biology in the Immunotherapy Era.
- 7 Aug 2026
- Current hematologic malignancy reports
Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia.
- 13 Jul 2026
- Current hematologic malignancy reports
Correction: Clonal Signatures of Telomere Biology Disorders.
- 10 Jul 2026
- Current hematologic malignancy reports
BRAF Alterations in Chronic Lymphocytic Leukemia: Genomic Landscape, Co-Mutation Patterns, and Clinical Relevance.
- 1 May 2026
- Current hematologic malignancy reports
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
- 25 Apr 2026
- Current hematologic malignancy reports
FAQs on Current Hematologic Malignancy Reports
How long has Current Hematologic Malignancy Reports been actively publishing? 
What is the publishing frequency of Current Hematologic Malignancy Reports? 
How many articles did Current Hematologic Malignancy Reports publish last year? 
What is the eISSN & pISSN for Current Hematologic Malignancy Reports? 
What is Citescore for Current Hematologic Malignancy Reports? 
What is the H Index for Current Hematologic Malignancy Reports ? 
What is SNIP score for Current Hematologic Malignancy Reports? 
What is the SJR for Current Hematologic Malignancy Reports? 
Who is the publisher of Current Hematologic Malignancy Reports? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary